Xtant Medical (NYSEAMERICAN:XTNT) Stock Crosses Above 200-Day Moving Average - Time to Sell?

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT - Get Free Report)'s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.60 and traded as high as $0.74. Xtant Medical shares last traded at $0.70, with a volume of 261,807 shares traded.

Xtant Medical Price Performance

The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.16 and a current ratio of 2.47. The company has a market capitalization of $98.59 million, a PE ratio of -17.61 and a beta of -0.22. The company's 50-day simple moving average is $0.63 and its 200-day simple moving average is $0.60.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of XTNT. Nantahala Capital Management LLC grew its position in Xtant Medical by 500.3% during the 2nd quarter. Nantahala Capital Management LLC now owns 68,394,000 shares of the medical device company's stock worth $50,543,000 after purchasing an additional 57,000,000 shares during the last quarter. AWM Investment Company Inc. purchased a new position in Xtant Medical during the 2nd quarter worth $4,875,000. Crescent Grove Advisors LLC grew its position in Xtant Medical by 94.3% during the 2nd quarter. Crescent Grove Advisors LLC now owns 412,024 shares of the medical device company's stock worth $304,000 after purchasing an additional 200,000 shares during the last quarter. Mink Brook Asset Management LLC grew its position in Xtant Medical by 125.8% during the 2nd quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company's stock worth $81,000 after purchasing an additional 60,997 shares during the last quarter. Finally, Jane Street Group LLC acquired a new stake in shares of Xtant Medical in the 2nd quarter worth $26,000. 69.33% of the stock is owned by hedge funds and other institutional investors.

About Xtant Medical

Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.